Annual Secretarial Compliance Report for the Financial Year Ended 31st March 2025
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care submitted its Annual Secretarial Compliance Report for FY25, audited by SPNP & Associates, Practicing Company Secretaries. The report confirms zero deviations, violations, or penalties during the review period (April 2024 to March 2025) under SEBI LODR Regulations and other applicable SEBI rules. All key compliance areas — secretarial standards, board policies, website disclosures, director eligibility, related party transactions, insider trading rules, and timely event disclosures — were marked as compliant. Two prior-period observations from FY24 (Audit Committee and Nomination & Remuneration Committee composition between 21–25 September 2023) were noted as already remediated, with independent directors appointed to restore compliance. No subsidiaries exist, no SEBI or stock exchange actions were taken against the company, and no statutory auditor resignations occurred.
This is a routine regulatory filing with no material negative impact on shareholders — the company has a clean compliance record for FY25 with no fines, penalties, or regulatory actions. The past committee composition issues were short-lived (5-day window) and have been fully corrected, signalling good governance hygiene.